ImmusanT is a privately help emerging biotech company focused on restoring tolerance to gluten in celiac disease by harnessing new discovereis in immunology that improve diagnosis and trement and return patients to a normal diet, good health, and improved quality of life. The company has a strong IP position and foudncation science which provides the basis for their peptide based immunotherapy and diagnostics.